Get 15% Off on World Health Day Flash Sale Get 15% Off on World Health Day Flash Sale

ADVERTISEMENT

Monsanto’s Secrets Exposed — Will Bayer AG Survive the Fallout?

Story at-a-glance -

  • August 10, 2018, a jury ruled in favor of the plaintiff, Dewayne Johnson, who claimed Monsanto’s Roundup caused his Non-Hodgkin lymphoma, and awarded Johnson $289 million in damages
  • According to the ruling, Monsanto “acted with malice or oppression” and was responsible for “negligent failure” by not warning consumers about the carcinogenicity of its product
  • Another Roundup-related trial is scheduled to begin in October, and there are an estimated 5,000 additional plaintiffs waiting in the wings for their day in court. All believe Roundup exposure caused their cancer
  • In the week following Johnson’s verdict, Bayer stock fell by 18 percent, evaporating about $14 billion of the company’s market value (a loss equivalent to 21 percent of Monsanto’s acquisition value)
  • Stock traders also cite lawsuits over dicamba-related crop damage as a driving factor for the stock plunge. Last year, over 3 million acres of U.S. farmland were destroyed by chemical burns from dicamba drift

By Dr. Mercola

Conspiracy is defined as "a secret plan by a group to do something unlawful or harmful." Discussing conspiracies is one of the fastest ways to be labeled a nut job, but the fact of the matter is that conspiracies do happen. Toxic industries have a long history of conspiring against the public good, and lately we've seen more and more proof of this reality in regard to toxic pesticides.


Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and are blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access